Skip to content
value.today

PAX Labs, Inc.

Formerly PAX Labs (Deux), Inc.

Total raised
$446 M
1 round on record
Latest round
$446 M
Apr 2019
First round on record
Apr 2019
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of PAX Labs, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2019$446 MNo. 1$250 million to $1 billion

PAX Labs, Inc.: Raise no. 1, Apr 2019

Investors in this round

142 investors had bought by the notice of Apr 29, 2019: 142 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 14 investors are named for PAX Labs, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$446 M of $446 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander Marcal · Executive Officer
  • Bharadwaj Srinivasan · Executive Officer, Director
  • Sharon Zezima · Executive Officer
  • Aaron Vermut · Director
  • Adam Bowen · Director, Promoter
  • James Monsees · Director, Promoter
  • Matthew Bigliardi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sharon Zezima, Secretary. Source: SEC Form D, newest notice filed Apr 29, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • PAX Labs, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2019).

    SEC Form D · Apr 2019

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Apr 2019

That is all the official record says: PAX Labs, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

14 named in official filings. Open an investor to see everything it has backed.

Investors in PAX Labs, Inc.
InvestorKindAmountRoundRoleSource
T. Rowe Price Health Sciences Fund, Inc.Fund or asset manager$2 Mheldnot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT
T. Rowe Price Small-Cap Stock Fund, Inc.Fund or asset manager$1 Mheldnot statedHeld shares (fund report, Mar 2026)SEC Form N-PORT
T. Rowe Price Small-Cap Value Fund, Inc.Fund or asset manager$1 Mheldnot statedHeld shares (fund report, Mar 2026)SEC Form N-PORT
T. Rowe Price Global Technology Fund, Inc.Fund or asset manager$1 Mheldnot statedHeld shares (fund report, Mar 2026)SEC Form N-PORT
T. Rowe Price All-Cap Opportunities FundFund or asset manager$1 Mheldnot statedHeld shares (fund report, Mar 2026)SEC Form N-PORT
T. Rowe Price Institutional Small-Cap Stock FundFund or asset manager$1 Mheldnot statedHeld shares (fund report, Mar 2026)SEC Form N-PORT
T. Rowe Price Global Stock FundFund or asset manager$0 Mheldnot statedHeld shares (fund report, Apr 2026)SEC Form N-PORT
T. Rowe Price Health Sciences PortfolioFund or asset manager$0 Mheldnot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT
T. Rowe Price All-Cap Opportunities PortfolioFund or asset manager$0 Mheldnot statedHeld shares (fund report, Mar 2026)SEC Form N-PORT
T. Rowe Price Spectrum Moderate Allocation FundFund or asset manager$0 Mheldnot statedHeld shares (fund report, Feb 2026)SEC Form N-PORT
T. Rowe Price Spectrum Moderate Growth Allocation FundFund or asset manager$0 Mheldnot statedHeld shares (fund report, Feb 2026)SEC Form N-PORT
T. Rowe Price Global Allocation FundFund or asset manager$0 Mheldnot statedHeld shares (fund report, Apr 2026)SEC Form N-PORT
T. Rowe Price Spectrum Conservative Allocation FundFund or asset manager$0 Mheldnot statedHeld shares (fund report, Feb 2026)SEC Form N-PORT
T. Rowe Price Moderate Allocation PortfolioFund or asset managernot statednot statedHeld shares (fund report, Mar 2026)SEC Form N-PORT

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 142 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by PAX Labs, Inc.
NameRoleNamed in
Alexander MarcalExecutive officerApr 2019
Bharadwaj SrinivasanExecutive officerApr 2019
Sharon ZezimaExecutive officerApr 2019
Aaron VermutDirectorApr 2019
Adam BowenDirectorApr 2019
Bharadwaj SrinivasanDirectorApr 2019
James MonseesDirectorApr 2019
Matthew BigliardiDirectorApr 2019
Adam BowenPromoterApr 2019
James MonseesPromoterApr 2019